% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Yin:284045,
author = {Yin, Yue and Li, Zixuan and Shu, Weijie and Liu, Hening and
Wang, Zihan and Fu, Cong and Zhu, Yuanbo and Li, Xuejing and
Zhang, Yi and Lv, Bei and Wang, Zixuan and Zhao, Qiaoqiao
and Liu, Dan and Tang, Lu and Wang, Wei},
title = {{I}ntranasal blood-brain barrier bypass enables sequential
mitochondria-targeted bioengineered nanolamellar system for
ischemic stroke therapy.},
journal = {Nature Communications},
volume = {17},
number = {1},
issn = {2041-1723},
address = {[London]},
publisher = {Springer Nature},
reportid = {DZNE-2026-00080},
pages = {760},
year = {2026},
abstract = {Mitochondrial damage constitutes the central pathological
mechanism of cerebral ischemia-reperfusion (I/R) injury.
Targeted delivery of antioxidants to mitochondria and the
phenotype polarization of glial cells holds great promise
for effective treatment. However, the blood-brain barrier
(BBB) remains a major obstacle, causing insufficient drug
accumulation in neuronal mitochondria. Here, we develop a
bioengineered nanolamellar system (MM@BPPF) by coating
microglia-mitochondria hybrid biomembrane onto black
phosphorus nanosheets (BP NSs) loaded with polymetformin
(PolyMet) and fingolimod hydrochloride (FTY720). Microglia
membrane facilitates inflammation-directed targeting to the
injured brain regions, while mitochondria membrane confers
homotypic targeting to mitochondria. Meanwhile, BP NSs,
PolyMet, and FTY720 act sequentially to restore
mitochondrial function of neuronal cells and modulate
microglial polarization. Intranasal administration enables
MM@BPPF to bypass the BBB, substantially improving
brain-targeting efficiency. This work not only offers an
innovative sequential targeting strategy for mitigating I/R
injury but also presents a potential paradigm for treating
other central nervous system disorders.},
keywords = {Blood-Brain Barrier: metabolism / Blood-Brain Barrier: drug
effects / Animals / Mitochondria: metabolism / Mitochondria:
drug effects / Microglia: metabolism / Microglia: drug
effects / Mice / Ischemic Stroke: drug therapy / Ischemic
Stroke: metabolism / Ischemic Stroke: pathology /
Administration, Intranasal / Fingolimod Hydrochloride:
administration $\&$ dosage / Fingolimod Hydrochloride:
pharmacology / Reperfusion Injury: drug therapy / Male /
Mice, Inbred C57BL / Drug Delivery Systems: methods /
Bioengineering / Neurons: drug effects / Neurons: metabolism
/ Disease Models, Animal / Brain: metabolism / Brain: drug
effects / Fingolimod Hydrochloride (NLM Chemicals)},
cin = {AG Liu},
ddc = {500},
cid = {I:(DE-2719)1012009},
pnm = {354 - Disease Prevention and Healthy Aging (POF4-354)},
pid = {G:(DE-HGF)POF4-354},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41547891},
doi = {10.1038/s41467-025-68024-5},
url = {https://pub.dzne.de/record/284045},
}